HCGNSEQ1FY26July 10, 2025

Healthcare Global Enterprises Limited

476words
2turns
0analyst exchanges
4executives
Management on call
B S Ajaikumar
Non-Executive Chairman
Manish Mattoo
Executive Director & Chief Executive Officer
Ruby Ritolia
Chief Financial Officer &
Ashutosh Kumar
VP – Strategic Planning & Corporate Development, HCG
Key numbers — 1 extracted
rs,
Mumbai - 400051, Maharashtra, India BSE Limited, Compliance Department, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400001, Maharashtra, India Dear Sir/Madam, Subject : Intimation of Ear
Advertisement
Speaking time
Subject
1
R SV P
1
Opening remarks
Subject
Intimation of Earnings call to discuss the Unaudited Financial Results of HealthCare Global Enterprises Limited (“the Company”) for the quarter ended June 30, 2025 Stock Code : BSE – 539787, NSE – HCG Reference : Regulation 30, Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Further to the intimation submitted to Stock Exchanges dated July 07, 2025, with respect to the meeting of the Board of Directors of the Company, to be held on Friday, August 01, 2025, inter-alia to consider, approve and take on record the Unaudited Financial Results (both Standalone and Consolidated) of the Company for the quarter ended June 30, 2025 (“Unaudited Financial Results”), we would like to inform you that, an Earnings Conference Call has been scheduled on Monday, August 04, 2025, at 10.00 a.m. (IST), to discuss the Unaudited Financial Results of the Company. The details of the Earnings Call are attached herewith. Kindly take the intimation on record
R SV P
Mr. Ashutosh Kumar – VP – Strategic Planning & Corporate Development, HCG E-Mail: ashutosh@hcgel.com Strategic Growth Advisors Pvt. Ltd. Mr. Sagar Shroff / Mr. Ayush Haria Contact: +91 98205 19303 / +91 98204 62966
Advertisement
← All transcriptsHCG stock page →